New LaunchJul 13, 2026, 08:31 AM
Enovis Launches CT-RevitL™ Veterinary Laser System in US
AI Summary
Enovis Corporation announced the U.S. launch of CT-RevitL™, its next-generation veterinary photobiomodulation (PBM) laser therapy system from its Companion Animal Health business. The new system, built on extensive research, offers enhanced clinical performance, greater mobility, and an intuitive treatment experience for veterinary teams. It incorporates Companion’s new COMPASS technology for precise dosing and is designed to support practice growth by expanding treatment offerings and improving client satisfaction. The system is available in the U.S. as of July 13, 2026, with international availability planned for later phases.
Key Highlights
- Enovis launched CT-RevitL™, a new veterinary PBM laser therapy system, in the U.S.
- The system is built on a foundation of over 150 published studies on photobiomodulation (PBM) therapy.
- CT-RevitL™ is designed to deliver deeper, faster, and more consistent therapeutic outcomes for animals.
- It features Companion’s new COMPASS technology for precise, calibrated dosing and treatment guidance.
- The system aims to improve clinical outcomes, practice efficiency, and support practice growth.
- CT-RevitL™ is available to veterinary practices across the United States starting July 13, 2026.
- International availability for the new system is anticipated in subsequent phases.
Price Impact
More from ENOV